The timing of esophagogastroduodenoscopy (EGD) in patients with esophageal food impaction (EFI) does not affect complication rates but is linked to higher hospitalizations when delayed, according to ...

Dual therapy with P-CAB helps mitigate clarithromycin resistance in treating H pylori infection. The most common treatment strategy for H pylori eradication is the combination of proton pump ...

From 1990 to 2021, the burden of antimicrobial resistance (AMR) decreased for those younger than 5 years and increased for those older than 70 years.

On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a “new option for receiving a safe and effective seasonal influenza vaccine ...

The FDA will decide on new drugs for rosacea, AADC deficiency, breast cancer, transthyretin amyloid cardiomyopathy, and biliary tract cancer.

Glycemic control achievement within the first 5 years of diabetes diagnosis has improved in non-White patients but still lags behind White patients.

Credit: Getty Images Our drug-drug interaction overview provides prescribers with information on drugs that may interact with GLP-1 agonists and SGLT-2 inhibitors. With the rising prescribing rates ...

Three of the 4 states had corresponding evidence of human influenza activity from other surveillance systems. HealthDay News — The findings from influenza A virus and H5 subtype monitoring of ...

Infants exposed to biologics in utero have no increased risk for adverse events when receiving rotavirus vaccination. The rotavirus vaccine appears safe for infants exposed to biologics in utero, ...

While naldemedine is efficacious for preventing opioid-induced constipation among individuals with cancer, long-term effects should be assessed. Naldemedine significantly prevents opioid-induced ...

An increase in county- and state-level cancer mortality rates was seen with higher county and state incarceration rates. HealthDay News — Higher incarceration rates are associated with increased ...

Patients who received a 3-dose series of the investigational PF-06425090 vaccine were less likely to require medical attention or antibiotic treatment for a primary Clostridioides difficile episode ...